Last reviewed 2026-05-28 · How we verify

THENIUM CLOSYLATE

FDA-approved active Small molecule ✓ Verified May 2026 Quality 6/100

THENIUM CLOSYLATE is a drug. It is currently FDA-approved.

Thenium closylate is a small molecule. It is also known by other names, including 611 C 65, 611-C-65, Closilate de Thenium, Closilato de Tenio, NSC-106569.

At a glance

Generic name	THENIUM CLOSYLATE
Modality	Small molecule
Therapeutic area	Other
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

THENIUM CLOSYLATE CI brief — competitive landscape report
THENIUM CLOSYLATE updates RSS · CI watch RSS

Frequently asked questions about THENIUM CLOSYLATE

What is THENIUM CLOSYLATE?

THENIUM CLOSYLATE is a Small molecule drug.

What development phase is THENIUM CLOSYLATE in?

THENIUM CLOSYLATE is FDA-approved (marketed).

Therapeutic area: All drugs in Other

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing